Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald B Kohn

Showing results (61-70 of 273) with videos related to

Pageof 28
Sort By:
Human Gene Therapy|March 14, 2009
Preloading potential of retroviral vectors is packaging cell clone dependent and centrifugation onto CH-296 ensures highest transduction efficiencyClaus S Sondergaard, Christa Haldrup, Christiane Beer, et al.
Cell Stem Cell|January 15, 2019
Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX SyndromeKatelyn E Masiuk, Jennifer Laborada, Maria Grazia Roncarolo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in miceMartina Blumenthal, Dianne Skelton, Karen A Pepper, et al.
Current Protocols in Stem Cell Biology|February 4, 2016
Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor CellsMegan D Hoban, Zulema Romero, Gregory J Cost, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2017
Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem CellsKatelyn E Masiuk, Devin Brown, Jennifer Laborada, et al.
Journal of Virological Methods|July 26, 2011
Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtrationAaron R Cooper, Sanjeet Patel, Shantha Senadheera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials NetworkEdwin M Horwitz, Mary M Horowitz, Nancy L DiFronzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locusAlok V Joglekar, Roger P Hollis, Gabriela Kuftinec, et al.
Mbio|December 7, 2021
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 VariantsF Javier Ibarrondo, Christian Hofmann, Ayub Ali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2023
Updated Management Guidelines for Adenosine Deaminase DeficiencyEyal Grunebaum, Claire Booth, Geoffrey D E Cuvelier, et al.
Pageof 28

Showing results (61-70 of 273) with videos related to

Sort By:
Pageof 28
Human Gene Therapy|March 14, 2009
Preloading potential of retroviral vectors is packaging cell clone dependent and centrifugation onto CH-296 ensures highest transduction efficiencyClaus S Sondergaard, Christa Haldrup, Christiane Beer, et al.
Cell Stem Cell|January 15, 2019
Lentiviral Gene Therapy in HSCs Restores Lineage-Specific Foxp3 Expression and Suppresses Autoimmunity in a Mouse Model of IPEX SyndromeKatelyn E Masiuk, Jennifer Laborada, Maria Grazia Roncarolo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Effective suicide gene therapy for leukemia in a model of insertional oncogenesis in miceMartina Blumenthal, Dianne Skelton, Karen A Pepper, et al.
Current Protocols in Stem Cell Biology|February 4, 2016
Delivery of Genome Editing Reagents to Hematopoietic Stem/Progenitor CellsMegan D Hoban, Zulema Romero, Gregory J Cost, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2017
Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem CellsKatelyn E Masiuk, Devin Brown, Jennifer Laborada, et al.
Journal of Virological Methods|July 26, 2011
Highly efficient large-scale lentiviral vector concentration by tandem tangential flow filtrationAaron R Cooper, Sanjeet Patel, Shantha Senadheera, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 25, 2010
Guidance for developing phase II cell therapy trial proposals for consideration by the Blood and Marrow Transplant Clinical Trials NetworkEdwin M Horwitz, Mary M Horowitz, Nancy L DiFronzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2013
Integrase-defective lentiviral vectors as a delivery platform for targeted modification of adenosine deaminase locusAlok V Joglekar, Roger P Hollis, Gabriela Kuftinec, et al.
Mbio|December 7, 2021
Previous Infection Combined with Vaccination Produces Neutralizing Antibodies with Potency against SARS-CoV-2 VariantsF Javier Ibarrondo, Christian Hofmann, Ayub Ali, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 3, 2023
Updated Management Guidelines for Adenosine Deaminase DeficiencyEyal Grunebaum, Claire Booth, Geoffrey D E Cuvelier, et al.
Pageof 28